SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genomic Valley Biotech informs about board meeting

06 Nov 2017 Evaluate

In pursuant to Reg. 29 of SEBI (LODR) Regulations, 2015, Genomic Valley Biotech has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, the 13th November, 2017, to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September, 2017 at G-74 Pushkar Enclave, Paschim Vihar, Delhi - 110063. Further pursuant to Reg. 30 of SEBI (LODR) Regulations, 2015 and SEBI (PIT) Regulations, 2015 and in compliances with Code of Conduct to Regulate, Monitor and Report, Trading by Insiders of the Company, the trading window for dealing in securities of the Company shall remain closed from 06th November, 2017 till 15th November, 2017.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

24.80 1.18 (5.00%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1683.25
Mangalam Global Ent 13.82
Kaveri Seed 983.30
Regaal Resources 97.07
Simran Farms 169.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×